---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009142"
form_type: "8-K"
ticker: "ACUT"
cik: "0001850767"
company_name: "Accustem Sciences Inc."
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:33:51.132509+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AccuStem Sciences sells 1.34M shares to Tiziana Life Sciences at $2.00/sh, raising $2.68M; CEO also joins board

## Summary
- Tiziana Life Sciences purchased 1,337,970 shares of AccuStem common stock at $2.00 per share for gross proceeds of $2,675,940.
- Sale was pursuant to a Supplemental Demerger Agreement from Oct 2021, requiring Tiziana to buy £2M shares at listing.
- Shares are unregistered and offered under Regulation S exemption.
- CEO Wendy Blosser appointed to the Board of Directors, effective March 30, 2022.

## SEC filing metadata
- accession: 0001493152-22-009142
- form_type: 8-K
- ticker: ACUT
- cik: 0001850767
- company_name: Accustem Sciences Inc.
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/0001493152-22-009142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009142
- JSON: https://secwatch.observer/filing/0001493152-22-009142.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009142.txt

## Key facts
- Executive change
  Wendy Blosser was appointed as director at Accustem Sciences Inc..
  - Action: appointed
  - Role: director
  source text: On March 30, 2022, the Board of Directors of the Company appointed Wendy Blosser, the Company’s Chief Executive Officer as a director to serve on the Board and to hold office until the next annual meeting of stockholders and until her successor is duly elected and qualified
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/0001493152-22-009142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.